Clinically proven weight loss, doctor-led and delivered to your door.
Wegovy(semaglutide) is a groundbreaking treatment, specifically licensed for weight management in Ireland.
It’s the first once-weekly GLP-1 medication developed exclusively for people seeking safe, sustainable weight loss — not just blood sugar control.
In clinical trials, patients using Wegovy lost an average of 15% of their body weight, combined with simple lifestyle changes like healthier eating and regular movement.
Scientifically Advanced Mechanism Wegovy works by mimicking the action of the naturally occurring hormone GLP-1 (glucagon-like peptide-1), targeting key pathways in the brain and body that regulate appetite and food intake.
The STEP 1 clinical trial followed over 1,900 adults using Wegovy alongside lifestyle changes. After 68 weeks, participants achieved significant weight loss and improvements in key health markers, demonstrating Wegovy’sl role in sustainable weight management.
Patients using Wegovy lost an average of 15% of their body weight over 68 weeks
Of patients lost more than 5% of their weight
Improvements recorded in heart health, blood pressure, and cholesterol levels
¹Results based on the STEP 1 clinical trial. Individual outcomes may vary.
Wegovy is a once-weekly injection that fits easily into your routine. You simply use a pre-filled pen under the skin (abdomen, thigh, or upper arm) — at any time of day, with or without food. To help your body adjust comfortably and minimise side effects, you’ll gradually increase your dose over several weeks.
This slow and steady approach gives you the best chance of success — and lasting weight loss.
Wegovy comes as a pre-filled injection pen and is taken once per week, at any time of day, with or without food.
1–4
5–8
9–12
13–16
Week 17+
0.25 mg
0.5 mg
1 mg
1.7 mg
2.4 mg (maintenance dose)
1–4
0.25 mg
5–8
0.5 mg
9–12
1 mg
13–16
1.7 mg
17+
2.4 mg (maintenance dose)
Some patients may adjust faster or slower depending on their needs. Once you reach your maintenance dose (2.4 mg weekly), you’ll stay there long-term to support sustained results.
You may qualify for Wegovy® if you are:
Eligibility is based on your full medical history. We’ll never prescribe unless it’s safe and appropriate for you.
Both treatments require medical supervision and regular check-ins to monitor your progress.
Both treatments require medical supervision and regular check-ins to monitor your progress.
Starting Your Wegovy® Journey Is Simple 3-Step Process
Complete a simple, secure online consultation (only takes a few minutes)
Select Wegovy® as your preferred treatment option
Once approved, your prescription will be sent to your chosen pharmacy. Alternatively, you can select a pharmacy in Northern Ireland for expedited delivery.
Both treatments require medical supervision and regular check-ins to monitor your progress.
Both treatments require medical supervision and regular check-ins to monitor your progress.
Currently, the HSE and most Irish health insurers do not cover weight loss injections specifically for weight management.
Both treatments require medical supervision and regular check-ins to monitor your progress.
Both treatments require medical supervision and regular check-ins to monitor your progress.
Both treatments require medical supervision and regular check-ins to monitor your progress.
Start your weight loss journey today — safely, privately, and with real results.
Disclaimer: Wegovy® and Mounjaro® are registered trademarks of their respective manufacturers. This website is not affiliated with, endorsed by, or sponsored by Novo Nordisk (Wegovy®) or Eli Lilly and Company (Mounjaro®). All trademarks are the property of their respective owners.
Disclaimer: Wegovy® and Mounjaro® are registered trademarks of their respective manufacturers. This website is not affiliated with, endorsed by, or sponsored by Novo Nordisk (Wegovy®) or Eli Lilly and Company (Mounjaro®). All trademarks are the property of their respective owners.
